PTC Therapeutics, Inc. (PTCT) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About PTC Therapeutics, Inc.
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally. The company provides Translarna and Emflaza for the treatment of Duchenne…
Source: Yahoo Finance
Sector & Industry
PTC Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
PTC Therapeutics, Inc. at a Glance
| Company | PTC Therapeutics, Inc. |
| Ticker | PTCT |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $69.30 |
| Market cap | $5.78B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$0.67 |
| 52-week high | $90.87 |
| 52-week low | $56.51 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.55 |
| Return on equity (ROE) | — |
| Debt-to-equity | — |
| Average volume | 1.64M |
| Shares outstanding | 83.46M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 991 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is PTC Therapeutics, Inc.'s current P/E ratio?
- PTC Therapeutics, Inc. (PTCT) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is PTC Therapeutics, Inc.'s market capitalisation?
- PTC Therapeutics, Inc.'s market cap is $5.78B based on our latest snapshot. See how it ranks by market cap →
- What is PTCT's 52-week range?
- Over the past 52 weeks, PTCT has traded between $56.51 and $90.87. What does the 52-week range mean? →
- How volatile is PTC Therapeutics, Inc. compared to the market?
- PTC Therapeutics, Inc. has a beta of 0.55, meaning it has historically moved less than the broader market. What does beta measure? →
- Does PTC Therapeutics, Inc. pay a dividend?
- PTC Therapeutics, Inc. does not currently pay a dividend according to our latest data.
- What exchange is PTCT listed on?
- PTCT is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is PTC Therapeutics, Inc. in?
- PTC Therapeutics, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →